Brief: Vimta Labs Enters Into Business Transfer Agreement With Thyrocare Technologies
Aug 30 (Reuters) - Vimta Labs Ltd VIML.NS :
* ENTERED INTO BUSINESS TRANSFER AGREEMENT WITH THYROCARE
TECHNOLOGIES
* TO SELL ITS DIAGNOSTICS, PATHOLOGICAL SERVICES BUSINESS TO
THYROCARE
* DEAL FOR 70 MILLION RUPEES
Source text for Eikon: ID:nBSE9YlpNx
Further company coverage: THYO.NS
(Reporting by VijayDattaram Malkar)
((VijayDattaram.Malkar@thomsonreuters.com;))
Recent news on Thyrocare Technologies
See all newsBrief: Thyrocare Technologies Limited Approves Sale Of Entire Shareholding In Nueclear Healthcare
India's Thyrocare hits record high after June-quarter profit rise
India's Thyrocare Technologies jumps to 5-month high after quarterly profit rise
Brief: Thyrocare Technologies Posts March-Qtr Consol Net Profit 471.2 Million Rupees
India's Thyrocare jumps on Phillip Capital initiation with 'Buy'